A
Waste of Taste
Taste alterations during therapy can make food unpleasant.
By Elizabeth Whittington
Whether it’s a large family meal during the holidays or
a comforting late-night snack, tasting and enjoying food is an
important part of people’s lives. Unfortunately, a large
percentage of patients find their sense of taste and smell changes
during cancer therapy. And although it may seem like a minor side
effect, taste alterations, also called dysgeusia, can significantly
impact a patient’s well-being and quality of life. Patients
with taste alterations may avoid certain food groups, which can
lead to vitamin deficiency and a lowered immune system, or avoid
food altogether, resulting in weight loss and poorer health.
“I
saw in my clinic that people were having problems tasting foods
and therefore not eating as much as they should and getting depressed
about it,” says
Jennifer Garst, MD, a lung cancer specialist at Duke University Medical Center
in Durham, North Carolina, who has a special interest in taste alterations. “I
saw problems with taste affecting them physically, possibly affecting the outcome
of treatment and quality of life.”
The four types of taste—sweet,
bitter, salty and sour—can be magnified,
muted or distorted. For example, foods may take on a bland or metallic taste.
There have also been rare instances where certain tastes have been switched,
such as salty foods tasting bitter.
Radiation and certain chemotherapy agents
are factors in altering taste and smell. Natasha Mirza, MD, associate
professor in the department of otorhinolaryngology, head and neck
surgery at the University of Pennsylvania, says there are several
theories to explain taste alteration. “There
is damage, especially with radiation, to tissues that are rapidly multiplying,
including taste buds,” Dr.
Mirza says.
Those with radiation to the head and neck are particularly at risk
for taste changes, which can begin several weeks after the first
session. Radiation can also damage the salivary glands. With less
saliva, the mouth doesn’t have
the ability to transfer food particles to the taste buds, which
can affect overall taste.
Although less damaging than radiation,
certain chemotherapy drugs cause dysgeusia in about 50 percent
of patients. Researchers believe cytotoxic drugs, including cisplatin,
Adriamycin® (doxorubicin), Taxol® (paclitaxel), methotrexate,
Cytoxan® (cyclophosphamide) and Oncovin® (vincristine),
selectively injure certain taste cells so people get an imbalance
of taste in their mouth.
Taste changes can also be caused by cancer
itself. “Many of the tumors
secrete substances that take away people’s drive to eat and
can change their taste,” says Dr. Garst.
Patients can take
steps to overcome taste alterations, including staying away from
favorite foods before chemotherapy sessions to prevent learned
food aversions and trying different foods as their tastes change.
To combat a metallic taste, experts recommend eating with plastic
utensils, and because meat can sometimes have a metallic aftertaste,
patients should try other protein-rich foods to fill the gap, such
as nuts, peanut butter, eggs and beans. Zinc sulfate supplements
may help improve taste, as well as rinsing the mouth with a mixture
of salt and baking soda (half a teaspoon each) with a cup of warm
water to neutralize aftertastes.
Results
of a study using flavor-enhancing powders with meals to test the
effect on cancer patients’ eating habits are expected later this year. Another
trial will study whether Marinol® (dronabinol), a synthetic cannabinoid used
to stimulate appetite, can improve food enjoyment for advanced cancer patients
who have taste alterations.
Substituting chemotherapy agents may also help patients
regain normal taste. Research has shown that pegylated liposomal
doxorubicin, a form of Adriamycin known as Doxil®, may not have the same taste-altering
effect as Adriamycin.
Very few patients have permanent taste alterations, with most
finding that normal taste returns within a few weeks to a couple
of months after therapy ends. Addressing taste changes is an issue
patients should discuss with their doctors, because it does have
an impact on overall nutrition, and consequently recurrence risk,
recovery and quality of life. “Patients need nutrition to
come out of therapy healthy,” says Dr. Mirza.